Phibro Animal Health (PAHC) Q4 2024 Earnings
PAHC·Reported February 5, 2025·After market close
Phibro Animal Health reported Q4 2024 revenue of $309.3M, missed analyst consensus of $347.0M by $37.7M. Diluted EPS came in at $0.54, beat the $0.40 consensus by $0.14.
Revenue
$309.3Mmissed by $37.7M
Consensus: $347.0MDiluted EPS
$0.54beat by $0.14
Consensus: $0.40
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Phibro Animal Health's Q4 2024 earnings report.
Phibro Animal Health (PAHC) reported Q4 2024 earnings on February 5, 2025 after market close.
Phibro Animal Health reported revenue of $309.3M and diluted EPS of $0.54 for Q4 2024.
Revenue missed the consensus estimate of $347.0M by $37.7M. EPS beat the consensus estimate of $0.40 by $0.14.
You can read the 10-Q periodic report (0001558370-25-000659) directly on SEC EDGAR. The filing index links above go to sec.gov.